[N-nitrosomethylurea in the chemotherapy of lymphogranulomatosis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012008:Recurrence; D012075:Remission, Spontaneous; D013921:Thrombocytopenia / Q000139:chemically induced; D014747:Vinblastine / Q000627:therapeutic use
D009607:Nitrosourea Compounds; D011344:Procarbazine; D014747:Vinblastine; D011239:Prednisolone
N-nitrozometilmochevina v khimioterapii limfogranulematoza